Selective activity of various nucleoside and nucleotide analogues against human herpesvirus 6 and 7

Antiviral Chemistry and Chemotherapy

Volumn 8, Issue 1, 1997, Pages 24-31

  Takahashi, K ^a   Suzuki, M ^a   Iwata, Y ^a   Shigeta, S ^a   Yamanishi, K ^b   De Clercq, E ^c  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Antiviral activity; Human herpesvirus 6 (HHV 6); Human herpesvirus 7 (HHV 7); Nucleoside analogues; Nucleotide analogues

Indexed keywords

2 AMINO 7 [(1,3 DIHYDROXY 2 PROPOXY)METHYL]PURINE; 2,6 DIAMINO 9 (2 PHOSPHONOMETHOXYETHYL)PURINE; 5 (2 BROMOVINYL) 2' DEOXYURIDINE; 9 (2 PHOSPHONYLMETHOXYETHYL)GUANINE; ACICLOVIR; ACYCLIC NUCLEOSIDE; ACYCLIC NUCLEOSIDE PHOSPHONATE; ADEFOVIR; ADEFOVIR DIPIVOXIL; ANTIVIRUS AGENT; CIDOFOVIR; DNA POLYMERASE; FOSCARNET; GANCICLOVIR; IDOXURIDINE; NUCLEOSIDE DERIVATIVE; NUCLEOTIDE DERIVATIVE; PHOSPHONOACETIC ACID; SORIVUDINE; TETRAZOLIUM; THYMIDINE KINASE; TRIFLURIDINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIDARABINE; VIRUS ENZYME;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG SELECTIVITY; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; PHOSPHORYLATION; PRIORITY JOURNAL; VIRUS REPLICATION;

EID: 0031035706     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029700800102     Document Type: Article

References (30)

1. Agut H, Collandre H, Aubin JT, Guetard D, Favier V, Ingrand D, Montagnier L & Huraux JM (1989) In vitro sensitivity of human herpesvirus 6 to antiviral drugs. Virus Research 14:219-228.
2. Agut H, Aubin JT & Huraux JM (1991) Homogeneous susceptibility of distinct human herpesvirus 6 strains to antivirals in vitro. Journal of Infectious Diseases 163:1382-1383.
3. Andrei G, Snoeck R, Schols D, Goubau P, Desmyter J & De Clercq E (1991) Comparative activity of selected antiviral compounds against clinical isolates of human cytomegalovirus. European Journal of Clinical Microbiology and Infectious Disease 10:1026-1033.
4. Aubin JT, Agut H, Collandre H, Yamanishi K, Chandran B, Montagnier L & Huraux JM (1993) Antigenic and genetic differentiation of the two putative types of human herpesvirus 6. Journal of Virological Methods 41:223-234.
5. Balzarini J, Holy A, Jindrich J, Naesens L, Snoeck R, Schols D & De Clercq E (1993) Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine. Antimicrobial Agents and Chemotherapy 37:332-338.
6. Burns WH & Sandford GR (1990) Susceptibility of human herpesvirus 6 to antivirals in vitro. Journal of Infectious Diseases 162:634-637.
7. Carrigan DR, Drobyski WR, Russler SK, Tapper MA, Knox KK & Ash RC (1991) Interstitial pneumonitis associated with human herpesvirus six (HHV-6) infection in marrow transplant patients. Lancet 338:147.
8. Di Luca D, Katsafanas G, Schirmer EC, Balachandran N & Frenkel N (1990) The replication of viral and cellular DNA in human herpesvirus 6-infected cells. Virology 175:199-210.
9. Downing RG, Sewankambo N, Serwadda D, Honess RW, Crawford D, Jarrett R & Griffen BE (1987) Isolation of human lymphotropic herpesvirus from Uganda. Lancet ii:390.
10. Drobyski WR, Dunne WM, Burd EM, Knox KK, Ash RC, Horowitz MM, Flomenberg N & Carrigan DR (1993) Human herpesvirus 6 (HHV-6) infection in allogeneic bone marrow transplant recipients : I. Evidence for a marrow suppressive role for HHV-6 in vivo. Journal of Infectious Diseases 167:735.
11. Frenkel N, Schirmer EC, Wyatt LS, Katsafanas G, Roffman E, Danovich RM & June CH (1990) Isolation of a new herpesvirus from human CD4+ T cells. Proceedings of the National Academy of Sciences, USA 87:748-752.
12. Gompels UA, Nicholas J, Lawrence G, Jones M, Thomson BJ, Martin MED, Efstathiou S, Craxton M & Macaulay HA (1995) The DNA sequence of human herpesvirus 6: structure, coding content and genome evolution. Virology 209:29-51.
13. Ho HT, Woods KL, Bronson JJ, De Boeck H, Martin JC & Hitchcock MJM (1991) Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl] cytosine. Molecular Pharmacology 41:197-202.
14. Kondo K, Kondo T, Okuno T, Takahashi M & Yamanishi K (1991) Latent human herpesvirus 6 infection of human monocytes/macrophages. Journal of General Virology 72:1401-1408.
15. Littler E, Stuart AD & Chee MS (1992) Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature 358:160-162.
16. Neyts J, Andrei G, Snoeck R, Jahne G, Winkler I, Helsberg M, Balzarini J & De Clercq E (1994) The N-7-substituted acyclic nucleoside analogue 2-amino-7-[1,3-dihydro-2-propoxy)methyl] purine is a potent and selective inhibitor of herpesvirus replication. Antimicrobial Agents and Chemotherapy 38:2710-2716.
17. Okuno T, Takahashi K, Balachandran K, Shiraki K, Yamanishi K, Takahashi M & Baba K (1989) Seroepidemiology of human herpesvirus 6 infection in normal children and adults. Journal of Clinical Microbiology 27:651-653.
18. Okuno T, Higashi K, Shiraki K, Yamanishi K, Takahashi M, Kokado Y, Ishibashi M, Takahara S, Sonoda T, Tanaka K, Baba K, Yabuuchi H & Kurata T (1990) Human herpesvirus 6 infection in renal transplantation. Transplantation 49:519-522.
19. Reymen D, Naesens L, Balzarini J, Holy A, Dvorakova H & De Clercq E (1995) Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6. Antiviral Research 28:343-357.
20. Russler SK, Tapper MA & Carrigan DR (1989) Susceptibility of human herpesvirus 6 to acyclovir and ganciclovir. Lancet ii:382.
21. Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, Halligan G, Biberfeld P, Wong-Staal F, Kramarsky B & Gallo RC (1986) Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234:596-601.
22. Snoeck R, Sakuma T, De Clercq E, Rosenberg I & Holy A (1988) (S)-1-(3-Hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication. Antimicrobial Agents and Chemotherapy 32:1839-1844.
23. Streicher HZ, Hung CL, Ablashi DV, Hellman K, Saxinger C, Fullen J & Salahuddin SZ (1988) In vitro inhibition of human herpesvirus 6 by phosphonoformate. Journal of Virological Methods 21:301-304.
24. Sullivan V, Talarico CL, Stanat SC, Davis M, Coen DM & Biron KK (1992) A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature 358:162-164.
25. Takahashi K, Sonoda S, Kawakami K, Miyata K, Oki T, Nagata H, Okuno T &. Yamanishi K (1988) Human herpesvirus 6 and exanthem subitum. Lancet i:1463.
26. Takeuchi H, Baba M & Shigeta S (1991) An application of tetrazolium (MTT) colorimetric assay for the screening of anti-herpes simplex virus compounds. Journal of Virological Methods 33:61-71.
27. Tanaka K, Kondo T, Torigoe S, Okada S, Mukai T & Yamanishi K (1994) Human herpesvirus 7: another causal agent for roseola (exanthem subitum). Journal of Pediatrics 125:1-5.
28. Tedder TS, Briggs M, Cameron CH, Honess RW, Robertson D & White H (1987) A novel lymphotropic herpesvirus. Lancet ii.-390-391.
29. Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y & Kurata T (1988) Identification of human herpesvirus 6 as a causal agent for exanthem subitum. Lancet ii:1065-1067.
30. Yoshikawa T, Suga S, Asano Y, Nakashima T, Yazaki T, Ono Y, Fujita T, Tsuzuki K, Sugiyama S & Oshima S (1992) A prospective study of human herpesvirus-6 infection in renal transplantation. Transplantation 54:879-883.